Clinical Drug Experience Knowledgebase

Adenocarcinoma (Phase 2)

Blast Crisis (Phase 2)

Breast Neoplasms (Phase 2)

Carcinoma (Phase 2)

Carcinoma, Hepatocellular (Phase 2)

Carcinoma, Non-Small-Cell Lung (Phase 2)

Carcinoma, Ovarian Epithelial (Phase 2)

Central Nervous System Neoplasms (Phase 1)

Colorectal Neoplasms (Phase 2)

Esophageal Neoplasms (Phase 2)

Gastrointestinal Stromal Tumors (Phase 2)

Graft vs Host Disease (Phase 2)

Hodgkin Disease (Phase 2)

Intestinal Neoplasms (Phase 2)

Leukemia (Phase 4)

Leukemia, Lymphocytic, Chronic, B-Cell (Phase 4)

Leukemia, Lymphoid (Phase 4)

Leukemia, Myelogenous, Chronic, BCR-ABL Positive (Phase 3)

Leukemia, Myeloid (Phase 3)

Leukemia, Myeloid, Acute (Phase 3)

Leukemia, Myelomonocytic, Acute (Phase 3)

Leukemia, Myelomonocytic, Chronic (Phase 3)

Leukemia, Myelomonocytic, Juvenile (Phase 3)

Lung Neoplasms (Phase 2)

Lymphoma (Phase 2)

Lymphoma, Mantle-Cell (Phase 2)

Lymphoma, Non-Hodgkin (Phase 1)

Lymphoma, T-Cell, Peripheral (Phase 2)

Melanoma (Phase 2)

Multiple Myeloma (Phase 2)

Myelodysplastic-Myeloproliferative Diseases (Phase 2)

Myelodysplastic Syndromes (Phase 3)

Myeloproliferative Disorders (Phase 1)

Neoplasm, Residual (Phase 2)

Neoplasms (Phase 2)

Neoplasms, Plasma Cell (Phase 2)

Ovarian Neoplasms (Phase 2)

Pancreatic Neoplasms (Phase 3)

Precursor Cell Lymphoblastic Leukemia-Lymphoma (Phase 2)

Preleukemia (Phase 3)

Prostatic Neoplasms (Phase 2)

Prostatic Neoplasms, Castration-Resistant (Phase 1)

Sarcoma (Phase 2)

Small Cell Lung Carcinoma (Phase 2)

Stomach Neoplasms (Phase 2)

Syndrome (Phase 3)

Triple Negative Breast Neoplasms (Phase 1)

Undifferentiated Connective Tissue Diseases (Phase 2)